Craft

Shanghai Pharmaceuticals

Stock Price

¥20.5

2024-10-29

Market Capitalization

¥64.5 B

2024-10-29

Revenue

¥281.7 B

FY, 2025

Shanghai Pharmaceuticals Summary

Company Summary

Overview
Shanghai Pharmaceuticals Holding (SPH, 上海医药集团股份有限公司) is a company that specializes in the field of drug development and healthcare services. It operates in research and development, manufacturing, distributionб and retail business sectors. The company develops drugs against chronic diseases, manufactures chemicals, healthcare products, and medical devices. SPH is focused on various therapeutic areas, including ocology, central nervous system (CNS), general infection, immunology, metabolism, etc. In addition, the company operates drugstore chains and provides related logistics services.
Type
Public
Status
Active
Founded
1994
HQ
Shanghai, CN | view all locations
Website
https://www.sphchina.com/index/index.html
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Cho Man

    Cho Man, Executive Director and President

    • Zhou Jun

      Zhou Jun, Chairman and Non-Executive Director

      • Shen Bo

        Shen Bo, Executive Director, Vice President, CFO

        • Li Yongzhong

          Li Yongzhong, Executive Director and Vice President

          LocationsView all

          2 locations detected

          • Shanghai, Shanghai Shi HQ

            China

            Shanghai Pharma Building, 200 Taicang Road

          • Hong Kong, Hong Kong Island

            Hong Kong

            26F Henley Building, 5 Queen’s Road

          Shanghai Pharmaceuticals Financials

          Summary Financials

          Revenue (Q1, 2026)
          ¥75.0B
          Gross profit (Q1, 2026)
          ¥7.9B
          Net income (Q1, 2026)
          ¥1.9B
          Cash (FY, 2025)
          ¥28.4B
          EBIT (Q1, 2026)
          ¥2.8B
          Enterprise value
          $97.1B

          Footer menu